Jump to content

Somatostatin receptor 5

From Wikipedia, the free encyclopedia
(Redirected from SSTR5)

SSTR5
Identifiers
AliasesSSTR5, SS-5-R, Somatostatin receptor 5
External IDsMGI: 894282; HomoloGene: 20287; GeneCards: SSTR5; OMA:SSTR5 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001053
NM_001172560
NM_001172572
NM_001172573

NM_001191008
NM_011425

RefSeq (protein)

NP_001044
NP_001166031

NP_001177937
NP_035555

Location (UCSC)Chr 16: 1.07 – 1.08 MbChr 17: 25.71 – 25.72 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Somatostatin receptor type 5 is a protein that in humans is encoded by the SSTR5 gene.[5]

Somatostatin acts at many sites to inhibit the release of many hormones and other secretory proteins. The biological effects of somatostatin are probably mediated by a family of G protein-coupled receptors that are expressed in a tissue-specific manner. SSTR5 is a member of the superfamily of receptors having seven transmembrane segments.[6]

Ligands

[edit]
Agonists

See also

[edit]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000162009 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000050824 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Takeda J, Fernald AA, Yamagata K, Le Beau MM, Bell GI (August 1995). "Localization of human somatostatin receptor 5 gene (SSTR5) to chromosome band 16p13.3 by fluorescence in situ hybridization". Genomics. 26 (3): 638–639. doi:10.1016/0888-7543(95)80195-R. PMID 7607700.
  6. "Entrez Gene: SSTR5 somatostatin receptor 5".
  7. Zhang Y, Wu N, Li Q, Hu X, Wang L, Sun JG, et al. (March 2021). "Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma". Experimental Eye Research. 204 108449. doi:10.1016/j.exer.2021.108449. PMID 33465395.
  8. WO 2022177988, Ferrara-Cook CU, Krasner AS, "Ferrara-Cook C, Krasner AS. Somatostatin receptor type 5 agonist for the treatment of hyperinsulinism. WO 2022/177988", published 2022-02-16, assigned to Crinetics Pharmaceuticals Inc [Us] and Crinetics Pharmaceuticals, Inc.

Further reading

[edit]
[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.